Phillip Kerewich

Phillip Kerewich has made 14 investments in companies such as: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic, Aileron Therapeutics, Raptor Pharmaceuticals, Elite Pharmaceuticals, Onconova Therapeutics, Phio Pharmaceuticals, InVivo Therapeutics, Plandai Biotechnology, Onstream Media, rMark Bio, Emmaus Medical.

Location of Phillip Kerewich is Chicago, United States.

The free version of Angel Match provides limited data for Phillip Kerewich. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Phillip Kerewich is a Vice President and he his investment types are: Venture Capital.
Phillip Kerewich focuses investing in industries such as: Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics, Biopharma, Hispanic / Latinx Founded, Women Founded, Life Science, Artificial Intelligence, Big Data, Business Intelligence, Cloud Computing, Collaboration, Software, CleanTech, Enterprise Software, Hardware, Manufacturing, Medical Device, Medical.

A short brief about investor:


Past investments

  • Nuo Therapeutics
  • X4 Pharmaceuticals
  • Ocata Therapeutics
  • Lightwave Logic
  • Aileron Therapeutics
  • Raptor Pharmaceuticals
  • Elite Pharmaceuticals
  • Onconova Therapeutics
  • Phio Pharmaceuticals
  • InVivo Therapeutics
  • Plandai Biotechnology
  • Onstream Media
  • rMark Bio
  • Emmaus Medical

Social media:

Available after registration.